News

On issuance, the patent will expire in 2022. The company said that the subsequently filed patent applications which broaden its patent position could extend the patent life for

Impax said that the FDA has requested the company to provide notification to Endo and Penwest of this certification. This paragraph IV certification notice refers to Penwest’s patents

The company said that tanespimycin is clearly active in patients who are refractory to trastuzumab and whose disease progressed prior to entering the study. Of 20 evaluable patients,

The two-year study will use the Corgenix hyaluronic acid (HA) test kit alone and in combination with other liver fibrosis biomarkers, to develop a predictive model for liver

This current study will test the long-term safety and tolerability of Vilazodone and will enroll patients at 40 sites in the US. A second pivotal trial will continue

With its acquisition of Encode, Bennu has obtained intellectual property rights related to EC Cysteamine, including an exclusive worldwide license to develop and market a product which has

The company’s pandemic influenza vaccine candidate is currently in Phase I/IIa clinical trials. In a study using mice, two injections of Novavax’s trivalent seasonal flu vaccine without an

The closing of the offering is subject to certain conditions, and is expected to occur on December 20, 2007. Leerink Swann served as lead placement agent for the

The institution’s principal investigator is Albert Cheung, department of anesthesiology, Hospital of the University of Pennsylvania. Ischemic spastic paraplegia is a painful form of extreme spasticity and rigidity